//
A Controlled Trial of Rivaroxaban After Transcatheter Aortic-Valve Replacement
Why and How to Measure Aortic Valve Calcification in Patients With Aortic Stenosis
Incidence and Outcomes of Surgical Bailout During TAVR : Insights From the STS/ACC TVT Registry
Anticoagulation After Surgical or Transcatheter Bioprosthetic Aortic Valve Replacement
Prognostic Value of Computed Tomography-Derived Extracellular Volume in TAVR Patients With Low-Flow Low-Gradient Aortic Stenosis
Rationale and design of a randomized clinical trial comparing safety and efficacy of Myval transcatheter heart valve versus contemporary transcatheter heart valves in patients with severe symptomatic aortic valve stenosis: the LANDMARK trial
Left Ventricular Hypertrophy and Clinical Outcomes Over 5 Years After TAVR: An Analysis of the PARTNER Trials and Registries
Prevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac Amyloidosis